Chief Corp. & Bus. Dev. Ofcr · Janux Therapeutics, Inc. · Common Stock
Side
SELL
Value
$57K
Shares
4,059
Price
$14.03
Executed
Jun 2, 2026
Disclosed
Jun 4, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jun 2 executedJun 4, 2026 disclosed
JANX · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Doyle Janeen Noel filed this Form 4 reporting a open-market sale of JANX on Jun 2, 2026. It became public on Jun 4, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Corp. & Bus. Dev. Ofcr
Doyle Janeen Noelcik:0002069239
Issuer
Janux Therapeutics, Inc.cik:0001817713
Revision history · 0
No field has changed since this record was first ingested.
